NCT03280082 (MUAC120) is a NA clinical trial of MUAC Program in Malnutrition, sponsored by Epicentre.

Who is sponsoring NCT03280082?

NCT03280082 is sponsored by Epicentre.

What drugs are being tested in NCT03280082?

Interventions in NCT03280082: MUAC Program, Standard Program.

What condition does NCT03280082 study?

NCT03280082 studies Malnutrition.

Is NCT03280082 still recruiting?

NCT03280082 is currently completed. Last updated 10 February 2021.

Last reviewed 2021-02-10 · How we verify

NCT03280082: MUAC120

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Use of MUAC as Basic Criterion for Admission, Follow-up and Exit From the Ambulatory Nutrition Program

Completed NA Last updated 10 February 2021

What this trial tests

NA trial testing MUAC Program in Malnutrition in 6,200 participants. Completed in 31 December 2020.

Timeline

25 June 2018

Primary endpoint
28 February 2019

31 December 2020

Quick facts

Lead sponsor	Epicentre
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	6,200
Start date	25 June 2018
Primary completion	28 February 2019
Estimated completion	31 December 2020
Sites	1 location across Niger

Drugs / interventions tested

MUAC Program
Standard Program

Conditions studied

Malnutrition — all drugs for Malnutrition →

Sponsor

Epicentre — full company profile →

Who can join

Adults 6 Months to 59 Months, any sex, with Malnutrition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to provide comprehensive documentation of the relevant results and operational implications of this new model using Mid-Upper Arm Circumference (MUAC) as the single anthropometric criterion for admission, monitoring and exit of non- complicated in Niger.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Estimating program coverage in the treatment of severe acute malnutrition: a comparative analysis of the validity and operational feasibility of two methods.
Isanaka S, Hedt-Gauthier BL, Grais RF, Allen BGS. · · 2018 · cited 2× · PMID 29970172 · DOI 10.1186/s12963-018-0167-3

Verify or expand the search:

Other recruiting trials for Malnutrition

Currently open trials in the same condition.

NCT07162701 — Body Composition Assessment and Monitoring in Inflammatory Bowel Disease · recruiting
NCT05324475 — Maintaining Immune and Mitochondrial Functions in Old Adults With SAfe Nutrition. · NA · recruiting
NCT06825377 — Comparing High-protein Vs. Standard Protein Nutritional Support in Critically Ill Patients At Risk for Refeeding Syndrom · NA · recruiting
NCT06687291 — Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer · recruiting
NCT06837194 — Washed Microbiota Transplantation Combined With Enteral Nutrition for Gastroptosis · recruiting

Other Epicentre trials

Trials by the same sponsor.

NCT06382857 — Effectiveness of a Microbiome-directed Food to Promote Programmatic and Sustained Nutritional Recovery Among Children Wi · NA · recruiting
NCT05551819 — Acceptability of a Microbiome-directed Food in Young Children With Acute Malnutrition · NA · completed
NCT07506213 — Development, Feasibility and Acceptability of Recipes for Locally Available, Specially Formulated Foods for the Manageme · NA · completed
NCT05453253 — Immune Response to a Delayed Second Dose of Oral Cholera Vaccine · Phase 4 · unknown
NCT05449717 — Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03280082 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Epicentre
Last refreshed: 10 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03280082.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing